Literature DB >> 20888111

[Basement of matrix therapy in regenerative medicine by RGTA(®): From fundamental to plastic surgery].

D Barritault1, S Garcia-Filipe, G Zakine.   

Abstract

Cells present continuous renewal, permitting permanent regeneration which is called tissue homeostasis. The signaling protein, known as growth factors, cytokines, interleukins and chemokines, but also the extracellular matrix play a key role in the cellular communication. All processes are deregulated after tissue injury, inducing scars. By reconstituting the extracellular matrix, it is possible to avoid the development of scar and to favorize the regeneration of the injured tissue. Glycosaminoglycans, and particularly heparan sulfates, by participating to the extracellular matrix structure, are implicated in cellular communication. This article describes how, by creating heparan sulfate mimetic or Regenerating Agent (RGTA), a French academic team has demonstrated that mammals have the ability to regenerate, by restoring the proper cellular micro-environment. After a first clinical development in two severe and chronic pathologies (corneal and skin ulcers), we show now the potential of these agents in plastic and reconstructive surgery, to regulate fibrosis and to enhance speed and quality of tissue healing.
Copyright © 2010. Published by Elsevier SAS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888111     DOI: 10.1016/j.anplas.2010.09.002

Source DB:  PubMed          Journal:  Ann Chir Plast Esthet        ISSN: 0294-1260            Impact factor:   0.660


  2 in total

1.  A heparan sulfate-based matrix therapy reduces brain damage and enhances functional recovery following stroke.

Authors:  Yacine Khelif; Jérôme Toutain; Marie-Sophie Quittet; Sandrine Chantepie; Xavier Laffray; Samuel Valable; Didier Divoux; Fernando Sineriz; Emanuelle Pascolo-Rebouillat; Dulce Papy-Garcia; Denis Barritault; Omar Touzani; Myriam Bernaudin
Journal:  Theranostics       Date:  2018-11-12       Impact factor: 11.556

2.  ReGeneraTing Agents (RGTA®) are a new option to improve amputation outcomes in the recovery of severe hand injuries.

Authors:  Roohi Sharifah Ahmad; Denis Barritault
Journal:  Clin Case Rep       Date:  2018-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.